• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Dengue

Dengue - 67 Studies Found

Completed : Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2010-05-27
:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4

Completed : A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2010-02-05
:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 vir

Active, not recruiting : Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2015-12-09
:
  • Biological: CYD Dengue Vaccine

Active, not recruiting : Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2015-12-03
:
  • Biological: CYD Dengue Vaccine (5-dose formulation)

Completed : Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
:
  • Dengue Shock Syndrome
  • Dengue Hemorrhagic Fever

: 2009-06-11
:
  • Biological: DEN4 Vaccine Candidate

Completed : Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever
  • Biological: ChimeriVax™ Tetravalent Dengue Vaccine

Completed : Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
:
  • Dengue
  • Dengue Fever
  • Dengue Hemorrhag
    : 2011-11-18
Completed : Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
:
  • Dengue
  • Dengue Fever
  • Dengue Hemorrhag
    : 2013-11-06
Completed : Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India
:
  • Dengue
  • Dengue Fever
  • Dengue Hemorrhag
    : 2012-03-07
    :
    • Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus

Active, not recruiting : Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
:
  • Dengue
  • Dengue Fever
  • Dengue Hemorrhag
    : 2011-06-08
    :
    • Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.